Delta-Omicron recombinant escapes therapeutic antibody neutralization
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2022.04.06.487325: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: Study approval: This study was approved by the NYULH Institutional Review Board, protocol numbers i21-00493 and i21-00561. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Virus isolation and culture: VeroE6/TMPRSS2 cells11 were used for virus isolation, obtained from the Japanese Collection of Research Bioresources (JCRB Cell Bank) cell number JCRB1819, through Sekisui Xenotech, LLC (Kansas City, KS), agreement # A2000230. VeroE6/TMPRSS2 cells were seeded three days prior to infection, to reach 85-90% confluency. VeroE6/T…SciScore for 10.1101/2022.04.06.487325: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: Study approval: This study was approved by the NYULH Institutional Review Board, protocol numbers i21-00493 and i21-00561. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Virus isolation and culture: VeroE6/TMPRSS2 cells11 were used for virus isolation, obtained from the Japanese Collection of Research Bioresources (JCRB Cell Bank) cell number JCRB1819, through Sekisui Xenotech, LLC (Kansas City, KS), agreement # A2000230. VeroE6/TMPRSS2 cells were seeded three days prior to infection, to reach 85-90% confluency. VeroE6/TMPRSS2suggested: JCRB Cat# JCRB1819, RRID:CVCL_YQ49)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
